Alterations in Endometrial Stromal Cell Tissue Factor Protein and Messenger Ribonucleic Acid Expression in Patients Experiencing Abnormal Uterine Bleeding while Using Norplant-2 Contraception

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1983-1988

  Runić, Radmila ^a   Schatz, Frederick ^a   Krey, Lewis ^a   Demopoulos, Rita ^a   Thung, Stephen ^a   Wan, Livia ^a   Lockwood, Charles J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL; MESSENGER RNA; THROMBOPLASTIN;

ARTICLE; BIOLOGY; BLEEDING; CHEMICALLY INDUCED DISORDER; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE IMPLANTS--SIDE EFFECTS; CONTRACEPTIVE METHODS--SIDE EFFECTS; CONTRACEPTIVE MODE OF ACTION; DEVELOPED COUNTRY; DISEASES; DRUG EFFECT; ENDOMETRIAL EFFECTS; ENDOMETRIUM; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; FEMALE; FEMALE GENITAL SYSTEM; GENETICS; GENITAL SYSTEM; HEMATOLOGICAL EFFECTS; HEMIC SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; LEVONORGESTREL--SIDE EFFECTS; METABOLISM; METHODOLOGY; NORTH AMERICA; NORTHERN AMERICA; PATHOLOGY; PHYSICAL DISEASE BY BODY FUNCTION; PHYSIOLOGY; STAINING; STROMA CELL; UNITED STATES; UROGENITAL SYSTEM; UTERUS; UTERUS BLEEDING; VASCULAR DISEASE; WESTERN HEMISPHERE;

AMERICAS; BIOLOGY; BLEEDING; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE IMPLANTS--SIDE EFFECTS; CONTRACEPTIVE METHODS--SIDE EFFECTS; CONTRACEPTIVE MODE OF ACTION; DEVELOPED COUNTRIES; DISEASES; ENDOMETRIAL EFFECTS; ENDOMETRIUM; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; HEMATOLOGICAL EFFECTS; HEMIC SYSTEM; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; LEVONORGESTREL--SIDE EFFECTS; NEW YORK; NORTH AMERICA; NORTHERN AMERICA; PHYSIOLOGY; RESEARCH METHODOLOGY; SIGNS AND SYMPTOMS; UNITED STATES; UROGENITAL SYSTEM; UTERUS; VASCULAR DISEASES;

CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEVONORGESTREL; RNA, MESSENGER; STAINING AND LABELING; STROMAL CELLS; THROMBOPLASTIN; UTERINE HEMORRHAGE;

EID: 0031156849     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.6.1983     Document Type: Article

References (29)

1. Forrest JD. 1994 Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol. 170:1485-1489.
2. Tyrer LB. 1994 Obstacles to use of hormonal contraception. Am J Obstet Gynecol. 170:1495-1498.
3. Darney PD. 1994 Hormonal implants: contraception for a new century. Am J Obstet Gynecol. 170:1536-1543.
4. Gu S-J, Du M-K, Zhang L-D, Liu Y-L, Wang S-H, Sivin I. 1994 A 5-year evaluation of NORPLANT contraceptive implants in China. Obstet Gynecol. 83:673-678.
5. Alexander NJ, d'Arcangue C. 1992 Preface. In: Alexander NJ, d'Arcangue C, eds. Steroid hormones and uterine bleeding. Washington DC: AAAS Press; 13-15.
6. Lockwood CJ, Nemerson Y, Krikun G, et al. 1993 Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab. 77:1014-1019.
7. Nemerson Y. 1988 Tissue factor and hemostasis. Blood. 71:1-8.
8. Lockwood CJ, Schatz F. 1996 A biological model for the regulation of periimplantational hemostasis and menstruation. J Soc Gynecol Invest. 3:159-165.
9. Eckert RL, Katzenellenbogen BS. 1981 Human endometrial cells in primary tissue culture: modulation of the progesterone receptor level by natural and synthetic estrogens in vitro. J Clin Endocrinol Metab. 52:699-708.
10. Lockwood CJ, Krikun G, Papp C, Aigner S, Nemerson Y, Schatz F. 1994 Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content. J Clin Endocrinol Metab. 79:786-790.
11. Shi S-R, Key ME, Kalra KL. 1991 Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 39:741-748.
12. Spicer EK, Horton R, Bloem L, et al. 1987 Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci USA. 84:5148-5152.
13. Runić R, Bardin CW, Schlegel PN. 1995 Zone-specific clusterin mRNA expression in the rat epididymis. Recent Prog Horm Res. 50:379-385.
14. Reynolds LP, Killilea SD, Redmer DA. 1992 Endometrial growth and vascular development: patterns and mediators. In: Alexander NJ, d'Arcangues C, eds. Steroid hormones and uterine bleeding. Washington DC: AAAS Press; 37-48.
15. Hourihan HM, Sheppard BL, Belsey EM, Brosens IA. 1991 Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception. 43:375-385.
16. Rogers PAW, Au CL, Affandi B. 1993 Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod. 8:1396-1404.
17. Goodger (Macpherson) AM, Rogers PAW, Affandi B. 1994 Endomotrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Hum Reprod. 9:1647-1651.
18. King RJB, d'Arcangues C. 1992 Steroid hormone effects on uterine blood vessels. In: Alexander NJ, d'Arcangues C, eds. Steroid hormones and uterine bleeding. Washington DC: AAAS Press; 25-36.
19. Lane G, King R, Whitehead M. 1988 The effect of oestrogens and progestogens on endometrial biochemistry. In: Studd JWW, Whitehead MI, eds. The menopause. Oxford: Blackwell; 213-226.
20. d'Arcangues C, Odlind V, Fraser IS. 1992 Dysfunctional uterine bleeding induced by exogenous hormones. In: Alexander NJ, d'Arcangues C, eds. Steroid hormones and uterine bleeding. Washington DC: AAAS Press; 81-105.
21. Wentz AC. 1988 Contraception and family planning. In: Jones III HW, Wentz AC, Burnett LS, eds. Novak's textbook of gynecology, 11th ed. Baltimore: Williams and Wilkins; 204-239.
22. Critchley HOD, Bailey DA, Au CL, Affandi B, Rogers PAW. 1993 Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum Reprod. 8:1632-1639.
23. Conneely OM, Maxwell BZ, Toft DO, Schrader WT, O'Malley BW. 1987 The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun. 149:493-501.
24. Christensen K, Estes PA, Onate SA, et. al. 1991 Characterization and functional properties of the A and B forms of the human progesterone receptors synthesized in a baculovirus system. Mol Endocrinol. 5:1755-1770.
25. Olsson S-E. 1987 Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study. Acta Obstet Gynecol Scand 142(Suppl):1-45.
26. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP. 1993 Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol. 7:1244-1255.
27. Meyer ME, Qurin-Stricker C, Lerouge T, Bocquel MT, Gronemeyer H. 1992 A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J Biol Chem. 267:10882-10887.
28. Boyd-Leinen P, Gosse B, Rasmussen K, Martin-Dani G, Spelsberg TC. 1984 Regulation of nuclear binding of the avian oviduct progesterone receptor. Changes during estrogen-induced oviduct development, withdrawal and secondary stimulation. J Biol Chem. 259:2411-2421.
29. Gao J, Wang S-L, Wu S-C, Sun B-L, Allonen H, Luukkainen T. 1990 Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant® implants in China. Contraception. 41:485-494.